NCT06370793

Ningbo Schizophrenia Cohort

Ningbo Schizophrenia Cohort, a Longitudinal Population-based Ambispective Cohort Study

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 26,899 (actual)
• Sponsor: Ningbo University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

In recent years, the prevalence of schizophrenia in China has continued to grow, and the burden of disease in society has continued to rise. In order to improve the prognosis of patients with schizophrenia and reduce the risk of disease relapse or readmission, researchers established a cohort based on the Ningbo Mental Health Information System in Ningbo, a sub-provincial city in the southern wing of the Yangtze River Delta of China, with a resident population of more than 9 million, and linked it to the residents' health records, and through the data linkage obtained data on patients in the full cycle of pre-onset, diagnosis, follow-up, disease changes and death, realising full-cycle management of patients with schizophrenia. Currently, NSC has accumulated data on more than 30,000 patients with schizophrenia and obtained multi-dimensional longitudinal information through long-term follow-up and data linkage. All diseases follow the World Health Organization International Classification of Diseases 10th Edition (ICD-10) for clinical coding, and available data include baseline demographics, past history, family history, social functioning deficit screening scale scores, risk assessment, and so on and longitudinal health information from electronic health records (EHR), providing a solid data base for future real-world studies.

Conditions

• Schizophrenia

Interventions

Type	Name	Description
OTHER	Patient with schizophrenia without intervention	Patients with schizophrenia identified based on exposures of interest to the study

Timeline

• Start date: 2018-07-01
• Primary completion: 2023-12-31
• Completion: 2026-12-31
• First posted: 2024-04-17
• Last updated: 2025-05-23

Locations

1 site across 1 country: China